Data / Form D filings / Vektor Medical, Inc.
Vektor Medical, Inc.: Form D filings
Vektor Medical, Inc., a biotechnology company in San Diego, CA, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on February 20, 2024, reports $28.9 million sold of a $37.5 million offering to 98 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9255 Towne Centre Drive, Suite 750, San Diego, CA, 92121
- Phone
- (858) 405-0094
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1732150
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | New notice | $37,498,887 | $28,898,880 | $8,600,007 | 98 | Feb 2, 2024 | sec.gov |
| Nov 15, 2019 | New notice | $5,000,000 | $3,598,976 | $1,401,024 | 22 | Nov 1, 2019 | sec.gov |
| Jul 26, 2018 | New notice | $11,310 | $11,310 | 1 | Jul 13, 2018 | sec.gov | |
| May 11, 2018 | New notice | $12,150 | $12,150 | 1 | Apr 27, 2018 | sec.gov | |
| Feb 27, 2018 | New notice | $2,500,000 | $370,000 | $2,130,000 | 4 | Feb 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joe S. Braidwood | Executive Officer | |
| C. David Adair | Director | |
| Lana S. Caron | Executive Officer | |
| Robert J. Krummen | Executive Officer, Director | |
| Shannon David St. Clair | Executive Officer | |
| Chris S. Villongco | Executive Officer | |
| Luc S. Marengere | Director | |
| Douglas S. Komen | Executive Officer | |
| Alexander M. Monko | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 19, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vektor Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.